Dehydrodieugenol B (20-60 mg/kg/weight) prevented pulmonary remodeling in an animal model of ALI by reducing inflammatory cells, lung edema, IL-6 and IL-1β levels, iNOS, and collagen content and expression. Here, IL6 is linked to acute respiratory distress syndrome.